semaglutide for parkinson's Weight-loss drug does not slow Alzheimer's disease, two clinical trials find semaglutide and alzheimer's disease Role

This analysis further assessed whether the increase in DRP was a GLP-1 specific effect, or rather caused by a robust and early glucose lowering as suggested by several other studies, where acute and large reductions in glucose concentrations may initially and transiently worsen DRP, yet prevent or delay onset or progression of DRP in the long term (123128)

GaribayDMcGaviganAKLeeSAFicorilliJVCoxALMichaelMDet al

This growth is predominantly fueled by a rising consumer demand for functional foods and dietary supplements aimed at weight management and energy enhancement, coupled with the robust expansion of the sports nutrition sector

Insufficient Weight Loss Despite Completing the Course 3.3

But the real-world data tells a different, far more interesting story